Maine § 32 §13844 Conditions or diseases managed; scope of practice

Maine Statutes

§ 32 §13844 — Conditions or diseases managed; scope of practice

Maine § 32 §13844

Title 32PROFESSIONS AND OCCUPATIONS

Ch. 117MAINE PHARMACY ACT

This text of Maine § 32 §13844 (Conditions or diseases managed; scope of practice) is published on Counsel Stack Legal Research, covering Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Me. Rev. Stat. tit. 32, § 32 §13844 (2026).

Text

1.Generally accepted standards of care. A pharmacist may engage in collaborative drug therapy management pursuant to a collaborative practice agreement only for conditions or diseases with generally accepted standards of care.

2.Prohibition. A pharmacist who is engaged in collaborative drug therapy management pursuant to a collaborative practice agreement may not, as part of the collaborative practice, participate in research or clinical or investigational trials.

3.Limitation. A collaborative practice agreement may include only the conditions or diseases to be managed that meet the qualifications and scope of practice for each party to the agreement.

Free access — add to your briefcase to read the full text and ask questions with AI

1.
Generally accepted standards of care.
A pharmacist may engage in collaborative drug therapy management pursuant to a collaborative practice agreement only for conditions or diseases with generally accepted standards of care.
2.
Prohibition.
A pharmacist who is engaged in collaborative drug therapy management pursuant to a collaborative practice agreement may not, as part of the collaborative practice, participate in research or clinical or investigational trials.
3.
Limitation.
A collaborative practice agreement may include only the conditions or diseases to be managed that meet the qualifications and scope of practice for each party to the agreement.